LP
GEN

LMR Partners’s Genesis Healthcare, Inc. GEN Stock Holding History

LMR Partners’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-33,392
Closed -$18K – 702
2020
Q3 		$18K Sell
33,392
-5,893
-15% -$4.24K ﹤0.01% 421
2020
Q2 		$27K Buy
+39,285
New +$31.6K ﹤0.01% 557

Other funds holding GEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LMR Partners's GEN Position: Q4 2020 in Review

LMR Partners sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 33,392 shares — an estimated $18K sold.

LMR Partners first reported a position in GEN in Q2 2020 and held it in 2 quarters. The position peaked at $27K in Q2 2020. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

  • LMR Partners reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
  • LMR Partners sold 33,392 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $18K.
  • LMR Partners first reported a position in Genesis Healthcare, Inc. in Q2 2020 and held it in 2 quarters.
  • LMR Partners's Genesis Healthcare, Inc. position peaked at $27K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on LMR Partners's 13F filing for Q4 2020, filed 16 Feb 2021.